Despite the downward trend in earnings at dormakaba Holding (VTX:DOKA) the stock ascends 4.7%, bringing one-year gains to 56%
After a strong gain in the past week, it's worth seeing if longer term returns have been driven by improving fundamentals.
Check out our latest analysis for dormakaba Holding
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
During the last year, dormakaba Holding actually saw its earnings per share drop 7.7%.
Given the share price gain, we doubt the market is measuring progress with EPS. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.
We doubt the modest 1.2% dividend yield is doing much to support the share price. Revenue was pretty stable on last year, so deeper research might be needed to explain the share price rise.
The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).
This free interactive report on dormakaba Holding's balance sheet strength is a great place to start, if you want to investigate the stock further.
It's good to see that dormakaba Holding has rewarded shareholders with a total shareholder return of 56% in the last twelve months. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 4% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 2 warning signs we've spotted with dormakaba Holding .
Of course dormakaba Holding may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Swiss exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Epoch Times
10 hours ago
- Epoch Times
WEF Investigation Finds ‘Minor Irregularities,' No Material Wrongdoing by Schwab
The World Economic Forum has cleared its founder, Klaus Schwab, of material wrongdoing following an internal investigation into allegations of financial and workplace misconduct. In an announcement published on Aug. 15, the Davos, Switzerland-based organization said the probe, conducted by Swiss law firm Homburger, identified 'minor irregularities' in expenses but concluded there was 'no evidence of material wrongdoing' by Schwab or his wife, Hilde Schwab.
Yahoo
12 hours ago
- Yahoo
Toyo introduces new ink system for flexographic printing
Toyo Ink Europe has launched a new low migration ink, called Steraflex GIO, to enhance its flexographic print performance. This new low migration ink is engineered to deliver print and press performance on various label substrates, sleeves, and applications where minimal migration is crucial. Steraflex GIO meets the stringent standards set by the European Printing Ink Association, Swiss Ordinance, the ECHA SVHC list, and other European regulations, including the German Ink Ordinance (GIO). It is said to be free from intentionally added photo initiator 379, thus meeting present and future stipulations of the GIO. This adherence instils confidence in printers and brand proprietors, especially when crafting packaging for delicate uses in the food and pharmaceutical industries, stated the company. The next-generation binder system in Steraflex GIO ensures enhanced adhesion on a wide array of substrates, including standard films and challenging label materials. It exhibits a significant improvement in bond strength, particularly on low-surface tension substrates such as biaxially oriented polypropylene, offering converters and brands more versatility without sacrificing the quality or safety of the print. Toyo Ink Europe sales and corporate strategy general manager Ismail Yilmaz said: "With increasing regulatory scrutiny on food packaging inks, compliance and transparency are more important than ever.' Additionally, the Toyo Ink Europe team has completed intensive training at Omet Demo Center to improve its flexographic expertise. The company said in a statement: 'This hands-on programme deepened our understanding of flexographic printing and brought together colleagues from different departments and regions to strengthen both our know-how and cooperation.' The session further bolstered the company's ongoing partnership with Italian distributor T&K. "Toyo introduces new ink system for flexographic printing " was originally created and published by Packaging Gateway, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 hours ago
- Yahoo
Swiss Economy Slows Sharply as Tariffs Weigh
Switzerland's economic growth slowed sharply in the second quarter, as strong frontrunning of U.S. tariffs in the early part of the year unwound, raising the chance that the Swiss central bank will cut interest rates to below zero later this year. Gross domestic product rose 0.1% in the three months to the end of June, down from the 0.8% growth of the first quarter, statistical agency SECO said in a flash estimate on Friday. Nobody's Buying Homes, Nobody's Switching Jobs—and America's Mobility Is Stalling The U.S. Alcohol Industry Is Reeling From Canada's Booze Boycott Are You a Stock Market Genius? Take Our Quiz. Rivian Says It Faces $100 Million Hole After Relaxation of Fuel Economy Rules Warren Buffett's Berkshire Further Pares Stake in Apple, Adds UnitedHealth Position Growth in the first three months of 2025 was led by U.S. stockpiling of Swiss goods exports, especially pharmaceuticals, a key sector for Swiss industry. Much of that has unraveled since as exports declined after President Trump's tariff announcements in early April. Contraction in industry was counterbalanced by gains in the services sector in the second quarter, SECO said. The agency said it would release more details on the breakdown on Aug. 28. The outlook for the future has grown more pessimistic. The Trump administration at the end of July said it would impose a 39% tariff rate on most Swiss imports, making Switzerland a rare country to be threatened with higher levies than originally announced. That tariff rate, one of the highest in the world, would cut the Alpine nation's GDP by about 0.5% over the next year, according to Goldman Sachs analysis. Industry association Swissmem called the outcome a 'horror scenario' and that it could cost Switzerland tens of thousands of jobs. However, there remain questions about the level of pharmaceutical tariffs yet to be decided by the U.S. In addition to pharmaceutical majors Roche and Novartis, Switzerland is also home to famed luxury watchmakers and the consumer-goods giant Nestle. 'The economy is likely to expand only slowly the next couple of quarters as high U.S. tariffs and elevated business uncertainty weigh on exports and investment,' Adrian Prettejohn, Europe economist at Capital Economics said in a note to clients. Alongside near-zero inflation, that will likely persuade the Swiss National Bank to cut its key rate below zero later this year, he added. The interest rate was last below zero for around eight years until 2022. The central bank has reduced its main interest rate to zero as it attempts to curtail the appreciating franc, which makes Swiss exports even less attractive. The franc has risen this year as investors flocked to the safe-haven currency amid choppy geopolitical waters. Write to Ed Frankl at The U.S. Is Discussing Taking a Stake in Intel What Musk, Altman and Others Say About AI-Funded 'Universal Basic Income' Mortgage Rates Slip to Lowest Level of 2025 China's Economy Shows Signs of Slowing, Raising Pressure on Beijing Americans' 401(k)s Are More Tied to Stocks Than Ever Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data